In my recent article, I discussed the benefits of the nootropic compound, 9-Methyl-Bcysine, also known as 9-Me-BC. It is interesting that this nootropic compound possesses certain health benefits. A research conducted by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health, showed that 9-me-bc powder causes the activation of a brain chemical call neurons in healthy human subjects. These neurons are thought to increase the production of dopamine, the brain chemical that is most associated with pleasurable sensations.
The neurons from people who took 9 methyl-carboline showed an increased sensitivity to pain as compared to subjects who received placebo. This was one of the first findings of this nootropic compound. Later studies showed that neurons in the spinal cord and the substantia nigra were activated by this nootropic compound as well. Preliminary findings show that 9-Me-BC does not cause abnormal behavior in mice when given to them in amounts equivalent to those found in some popular products sold today such as chocolate. This also indicates that there are no detrimental side effects of this nootropic compound. Hence, it can be used for purposes as prescribed and without fear of adverse reactions.
Another research found no adverse effects of 9-me-bc on lab rats. Unlike earlier studies, this one found no abnormalities in mice treated with cerebral palsy. However, long-term 9-Me-BC benefits on humans remain to be proven. It has, however, been found that the nootropic compound can prevent the onset of Parkinson’s disease. Long-term effects on the nervous system seem to differ from one individual to another, but recent studies have shown that people taking this nootropic agent seem to have less wrinkles and a stronger sense of well-being, compared to non-nourished individuals.
A growing body of literature indicates that 9-me-bc benefits brain health by regulating inflammation and improving neurotransmission in the brain. It has been found that 9-Me-BC reduces inflammation through reducing the levels of interleukins, which play an important role in the process of brain inflammation. It also prevents the activation of cytokines, which are involved in the process of brain inflammation. The nootropic compound provides support to the brain through the development of synapses. As synapses improve, cognitive function is improved. Long-term 9-Me-BC treatment can reduce the progression of mild Alzheimer’s disease and ameliorate poor cognitive function in patients with Parkinson’s disease.
Neuronal plasticity, the process of changes in how neurons fire together and how those firing together change with experience, has been shown to be enhanced by the introduction of a nutritional supplement called 9-Me-BC which people can get from 9-me-bc manufacturer. The nutritional compound enhances dopamine synthesis in the nucleus of the cell that produces the chemical agent tetrahydrotestosterone (THT). In studies on mice and rats, the nootropic compound had anti-inflammatory effects, reduced the excitatory activity of neurons, and improved the cognitive function, as evaluated using the Morris maze paradigm. Other studies have shown that the nootropic compound has neuroprotective, anti-oxidant, and anti-mutagenic properties and is capable of improving mood, suppressing neurodegenerative diseases like Alzheimer’s and Parkinsons, and regulating serotonin levels in the brain.